Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-blind, Multi-centre Placebo Controlled Trial of Dexmedetomidine for Patients With Agitation and Delirium in the Intensive Care Unit

NCT01151865 is registered in ClinicalTrials.gov with Austin Health as lead sponsor.

NCT NCT01151865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01151865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-blind, Multi-centre Placebo Controlled Trial of Dexmedetomidine for Patients With Agitation and Delirium in the Intensive Care Unit
Lead sponsor
Austin Health
Phase
Phase 2/3
Overall status
Completed
Start date
February 28, 2011
Completion date
December 31, 2013
Enrollment
96 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

delirium